FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Patricia Donahoe

Research Profile

Chemicals & Drugs

Anatomy

Living Beings

Disorders

Concepts & Ideas

Molecular Sequence Data

Physiology

Cell Divisions

Co-author Network

Publications

TOP 3
Nelson A Arango; Deepa Dabir; Carla Koehler; Li Li; Naifang Lu; John R McCarrey; Fotini Nicolau; Rafael Pieretti-Vanmarcke; Patricia K Donahoe
Meiosis I arrest abnormalities lead to severe oligozoospermia in meiosis 1 arresting protein (M1ap)-deficient mice.
Mauro Longoni; Maria Loscertales; Faouzi I Maalouf; Kristin M Noonan; Ji H Park; Alan Rope; Meaghan K Russell; Osamu Shimokawa; Bernarda Strauss; Adam A Tracy; Dagmar Wieczorek; Elaine H Zackai; Omar A Abdul-Rahman; Gareth Baynam; Steven B Bleyl; Paul D Brady; Jeroen Breckpot; Chih P Chen; Caroline M Coletti; koenraad devriendt; Patricia K Donahoe; Gabriele Gillessen-Kaesbach; Arthur W Grix; Kasper Lage; Charles Lee; Barbara R Pober
Congenital diaphragmatic hernia interval on chromosome 8p23.1 characterized by genetics and protein interaction networks.
Kasper Lage; Blake C Ballif; Søren Brunak; Mark J Daly; Patricia K Donahoe; Joshua M Gorham; Steven C Greenway; Sonia M Mesquita; William T Pu; Amy E Roberts; Jill A Rosenfeld; Ayellet V Segrè; Christine E Seidman; Jonathan G Seidman; Lisa G Shaffer; Leslie B Smoot; Niels Tommerup; Hiroko Wakimoto; Alexandre C Pereira; Lars A Larsen
Genetic and environmental risk factors in congenital heart disease functionally converge in protein networks driving heart development.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Patricia Donahoe (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Nelson A Arango; Deepa Dabir; Carla Koehler; Li Li; Naifang Lu; John R McCarrey; Fotini Nicolau; Rafael Pieretti-Vanmarcke; Patricia K Donahoe
Meiosis I arrest abnormalities lead to severe oligozoospermia in meiosis 1 arresting protein (M1ap)-deficient mice.
Biology of reproduction 2013;88(3):76.
2012: Mauro Longoni; Maria Loscertales; Faouzi I Maalouf; Kristin M Noonan; Ji H Park; Alan Rope; Meaghan K Russell; Osamu Shimokawa; Bernarda Strauss; Adam A Tracy; Dagmar Wieczorek; Elaine H Zackai; Omar A Abdul-Rahman; Gareth Baynam; Steven B Bleyl; Paul D Brady; Jeroen Breckpot; Chih P Chen; Caroline M Coletti; koenraad devriendt; Patricia K Donahoe; Gabriele Gillessen-Kaesbach; Arthur W Grix; Kasper Lage; Charles Lee; Barbara R Pober
Congenital diaphragmatic hernia interval on chromosome 8p23.1 characterized by genetics and protein interaction networks.
American journal of medical genetics. Part A 2012;158A(12):3148-58.
2012: Kasper Lage; Blake C Ballif; Søren Brunak; Mark J Daly; Patricia K Donahoe; Joshua M Gorham; Steven C Greenway; Sonia M Mesquita; William T Pu; Amy E Roberts; Jill A Rosenfeld; Ayellet V Segrè; Christine E Seidman; Jonathan G Seidman; Lisa G Shaffer; Leslie B Smoot; Niels Tommerup; Hiroko Wakimoto; Alexandre C Pereira; Lars A Larsen
Genetic and environmental risk factors in congenital heart disease functionally converge in protein networks driving heart development.
Proceedings of the National Academy of Sciences of the United States of America 2012;109(35):14035-40.
2012: Meaghan K Russell; Adam A Tracy; Julie Wells; Kate G Ackerman; Carol J Bult; Kasper Lage; Mauro Longoni; Maria Loscertales; Faouzi I Maalouf; Barbara R Pober; Patricia K Donahoe
Congenital diaphragmatic hernia candidate genes derived from embryonic transcriptomes.
Proceedings of the National Academy of Sciences of the United States of America 2012;109(8):2978-83.
2012: Katia Meirelles; David Pepin; Frederic Preffer; Pradeep Singh Tanwar; Jose Teixeira; Leo Andrew Benedict; David Dombkowski; Patricia K Donahoe; David T MacLaughlin; Robert H Young; Xiaolong Wei
Human ovarian cancer stem/progenitor cells are stimulated by doxorubicin but inhibited by Mullerian inhibiting substance.
Proceedings of the National Academy of Sciences of the United States of America 2012;109(7):2358-63.
2011: Henry L Chang; Rafael Pieretti-Vanmarcke; Fotini Nicolaou; Xianlin Li; Xiaolong Wei; David T MacLaughlin; Patricia K Donahoe
Mullerian inhibiting substance inhibits invasion and migration of epithelial cancer cell lines.
Gynecologic oncology 2011;120(1):128-34.
2010: Xiaolong Wei; David Dombkowski; Katia Meirelles; Rafael Pieretti-Vanmarcke; Paul P Szotek; Henry L Chang; Frederic Preffer; Peter R Mueller; Jose Teixeira; David T MacLaughlin; Patricia K Donahoe
Mullerian inhibiting substance preferentially inhibits stem/progenitors in human ovarian cancer cell lines compared with chemotherapeutics.
Proceedings of the National Academy of Sciences of the United States of America 2010;107(44):18874-9.
2010: Sibel Kantarci; Kate G Ackerman; Meaghan K Russell; Mauro Longoni; Carrie Sougnez; Kristin M Noonan; Eli Hatchwell; Xiaoyun Zhang; Rafael Pieretti Vanmarcke; Kwame Anyane-Yeboa; Paul Dickman; Jay Wilson; Patricia K Donahoe; Barbara R Pober
Characterization of the chromosome 1q41q42.12 region, and the candidate gene DISP1, in patients with CDH.
American journal of medical genetics. Part A 2010;152A(10):2493-504.
2010: David T MacLaughlin; Patricia K Donahoe
Müllerian inhibiting substance/anti-Müllerian hormone: a potential therapeutic agent for human ovarian and other cancers.
Future oncology (London, England) 2010;6(3):391-405.
2010: Thanos D Papakostas; Rafael Pieretti-Vanmarcke; Fotini Nicolaou; Aristomenis Thanos; George Trichonas; Xanthi Koufomichali; Kosisochukwu Anago; Patricia K Donahoe; Jose Teixeira; David T MacLaughlin; Demetrios Vavvas
Development of an efficiently cleaved, bioactive, highly pure FLAG-tagged recombinant human Mullerian Inhibiting Substance.
Protein expression and purification 2010;70(1):32-8.
2010: Henry L Chang; Tharanga N Senaratne; Lihua Zhang; Paul P Szotek; Ethan Stewart; David Dombkowski; Frederic Preffer; Patricia K Donahoe; Jose Teixeira
Uterine leiomyomas exhibit fewer stem/progenitor cell characteristics when compared with corresponding normal myometrium.
Reproductive sciences (Thousand Oaks, Calif.) 2010;17(2):158-67.
2010: Tetsu Hayashida; Fumiyuki Takahashi; Naokazu Chiba; Elena Brachtel; Motomi Takahashi; Nadia Godin-Heymann; Kenneth W Gross; Maria d M Vivanco; Vasuki Wijendran; Toshihiro Shioda; Dennis C Sgroi; Patricia K Donahoe; Shyamala Maheswaran
HOXB9, a gene overexpressed in breast cancer, promotes tumorigenicity and lung metastasis.
Proceedings of the National Academy of Sciences of the United States of America 2010;107(3):1100-5.
2009: Patricia K Donahoe
A pediatric surgeon retools in genetics and genomics to study congenital diaphragmatic hernia.
Journal of pediatric surgery 2009;44(2):307-11.
2009: Akihiro Fujino; Nelson A Arango; Yong Zhan; Thomas F Manganaro; Xianlin Li; David T MacLaughlin; Patricia K Donahoe
Cell migration and activated PI3K/AKT-directed elongation in the developing rat Müllerian duct.
Developmental biology 2009;325(2):351-62.
2008: Paul P Szotek; Henry L Chang; Kristen Brennand; Akihiro Fujino; Rafael Pieretti-Vanmarcke; Cristina Lo Celso; David Dombkowski; Frederic Preffer; Kenneth S Cohen; Jose Teixeira; Patricia K Donahoe
Normal ovarian surface epithelial label-retaining cells exhibit stem/progenitor cell characteristics.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(34):12469-73.
2008: Sibel Kantarci; Nicola K Ragge; N Simon Thomas; David O Robinson; Kristin M Noonan; Meaghan K Russell; Dian Donnai; F Lucy Raymond; Christopher Walsh; Patricia K Donahoe; Barbara R Pober
Donnai-Barrow syndrome (DBS/FOAR) in a child with a homozygous LRP2 mutation due to complete chromosome 2 paternal isodisomy.
American journal of medical genetics. Part A 2008;146A(14):1842-7.
2008: Maria Loscertales; Amanda Mikels; Jimmy Kuang-Hsein Hu; Patricia K Donahoe; Drucilla J Roberts
Chick pulmonary Wnt5a directs airway and vascular tubulogenesis.
Development (Cambridge, England) 2008;135(7):1365-76.
2008: Patricia K Donahoe
The mandate for innovation in pediatric surgery; creating the environment for success, parity, and excellence.
Journal of pediatric surgery 2008;43(1):1-7.
2008: Nina Renlund; Rafael Pieretti-Vanmarcke; Francis O'Neill; LiHua Zhang; Patricia K Donahoe; Jose Teixeira
c-Jun N-terminal kinase inhibitor II (SP600125) activates Mullerian inhibiting substance type II receptor-mediated signal transduction.
Endocrinology 2008;149(1):108-15.
2007: Jeremy T Aidlen; Pradeep P Nazarey; T Bernard Kinane; Patricia K Donahoe; Jay J Schnitzer; David E Kling
Retinoic acid-mediated differentiation protects against nitrofen-induced apoptosis.
Birth defects research. Part B, Developmental and reproductive toxicology 2007;80(5):406-16.
2007: Sibel Kantarci; Lihadh Al-Gazali; R Sean Hill; Dian Donnai; Graeme C M Black; Eric Bieth; Nicolas Chassaing; Didier Lacombe; koenraad devriendt; Ahmad Teebi; Maria Loscertales; Caroline Robson; Tianming Liu; David T MacLaughlin; Kristin M Noonan; Meaghan K Russell; Christopher Walsh; Patricia K Donahoe; Barbara R Pober
Mutations in LRP2, which encodes the multiligand receptor megalin, cause Donnai-Barrow and facio-oculo-acoustico-renal syndromes.
Nature genetics 2007;39(8):957-9.
2007: Akihiro Fujino; Rafael Pieretti-Vanmarcke; Anita Wong; Patricia K Donahoe; Nelson A Arango
Sexual dimorphism of G-protein subunit Gng13 expression in the cortical region of the developing mouse ovary.
Developmental dynamics : an official publication of the American Association of Anatomists 2007;236(7):1991-6.
2007: Sibel Kantarci; Patricia K Donahoe
Congenital diaphragmatic hernia (CDH) etiology as revealed by pathway genetics.
American journal of medical genetics. Part C, Seminars in medical genetics 2007;145C(2):217-26.
2007: Paul P Szotek; Henry L Chang; LiHua Zhang; Frederic Preffer; David Dombkowski; Patricia K Donahoe; Jose Teixeira
Adult mouse myometrial label-retaining cells divide in response to gonadotropin stimulation.
Stem cells (Dayton, Ohio) 2007;25(5):1317-25.
2007: Vandana Gupta; Giminna Yeo; Hirofumi Kawakubo; Vivek Rangnekar; Preethi Ramaswamy; Tetsu Hayashida; David T MacLaughlin; Patricia K Donahoe; Shyamala Maheswaran
Mullerian-inhibiting substance induces Gro-beta expression in breast cancer cells through a nuclear factor-kappaB-dependent and Smad1-dependent mechanism.
Cancer research 2007;67(6):2747-56.
2007: Lee-Ming Kow; Cristina Florea; Marlene Schwanzel-Fukuda; Nino Devidze; Hosein Kami Kia; Anna Lee; Jin Zhou; David T MacLaughlin; Patricia K Donahoe; Donald Pfaff
Development of a sexually differentiated behavior and its underlying CNS arousal functions.
Current topics in developmental biology 2007;79():37-59.
2006: Rafael Pieretti-Vanmarcke; Patricia K Donahoe; Lisa A Pearsall; Daniela M Dinulescu; Denise C Connolly; Elkan F Halpern; Michael Seiden; David T MacLaughlin
Mullerian Inhibiting Substance enhances subclinical doses of chemotherapeutic agents to inhibit human and mouse ovarian cancer.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(46):17426-31.
2006: Trinh T Tran; Dorry L Segev; Vandana Gupta; Hirofumi Kawakubo; Giminna Yeo; Patricia K Donahoe; Shyamala Maheswaran
Mullerian inhibiting substance regulates androgen-induced gene expression and growth in prostate cancer cells through a nuclear factor-kappaB-dependent Smad-independent mechanism.
Molecular endocrinology (Baltimore, Md.) 2006;20(10):2382-91.
2006: Nelson A Arango; Tiffany T Huang; Akihiro Fujino; Rafael Pieretti-Vanmarcke; Patricia K Donahoe
Expression analysis and evolutionary conservation of the mouse germ cell-specific D6Mm5e gene.
Developmental dynamics : an official publication of the American Association of Anatomists 2006;235(9):2613-9.
2006: Paul P Szotek; Rafael Pieretti-Vanmarcke; Peter T Masiakos; Daniela M Dinulescu; Denise Connolly; Rosemary Foster; David Dombkowski; Frederic Preffer; David T MacLaughlin; Patricia K Donahoe
Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(30):11154-9.
2006: Mary E Fallat; Patricia K Donahoe
Intersex genetic anomalies with malignant potential.
Current opinion in pediatrics 2006;18(3):305-11.
2006: Yong Zhan; Akihiro Fujino; David T MacLaughlin; Thomas F Manganaro; Paul P Szotek; Nelson A Arango; Jose Teixeira; Patricia K Donahoe
Müllerian inhibiting substance regulates its receptor/SMAD signaling and causes mesenchymal transition of the coelomic epithelial cells early in Müllerian duct regression.
Development (Cambridge, England) 2006;133(12):2359-69.
2006: Patricia K Donahoe
Genomic approaches to surgical diseases: 21st annual Samuel Jason Mixter lecture.
Archives of surgery (Chicago, Ill. : 1960) 2006;141(4):409-13.
2006: Rafael Pieretti-Vanmarcke; Patricia K Donahoe; Paul P Szotek; Thomas F Manganaro; Mary K Lorenzen; James Lorenzen; Denise C Connolly; Elkan F Halpern; David T MacLaughlin
Recombinant human Mullerian inhibiting substance inhibits long-term growth of MIS type II receptor-directed transgenic mouse ovarian cancers in vivo.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(5):1593-8.
2006: David E Kling; Kirra L Brandon; Christina A Sollinger; Amanda J Cavicchio; Qingyuan Ge; Thomas B Kinane; Patricia K Donahoe; Jay J Schnitzer
Distribution of ERK1/2 and ERK3 during normal rat fetal lung development.
Anatomy and embryology 2006;211(2):139-53.
2006: Sibel Kantarci; D Casavant; C Prada; M Russell; J Byrne; L Wilkins Haug; R Jennings; S Manning; F Blaise; T K Boyd; J P Fryns; Lewis B Holmes; Patricia K Donahoe; C Lee; Virginia E Kimonis; Barbara R Pober
Findings from aCGH in patients with congenital diaphragmatic hernia (CDH): a possible locus for Fryns syndrome.
American journal of medical genetics. Part A 2006;140(1):17-23.
2005: Nelson A Arango; Paul P Szotek; Thomas F Manganaro; Esther Oliva; Patricia K Donahoe; Jose Teixeira
Conditional deletion of beta-catenin in the mesenchyme of the developing mouse uterus results in a switch to adipogenesis in the myometrium.
Developmental biology 2005;288(1):276-83.
2005: Barbara R Pober; Angela Lin; Meaghan Russell; Kate G Ackerman; Sharmila Chakravorty; Bernarda Strauss; Marie-Noel Westgate; Jay Wilson; Patricia K Donahoe; Lewis B Holmes
Infants with Bochdalek diaphragmatic hernia: sibling precurrence and monozygotic twin discordance in a hospital-based malformation surveillance program.
American journal of medical genetics. Part A 2005;138A(2):81-8.
2005: Vandana Gupta; Jennifer L Carey; Hirofumi Kawakubo; Alona Muzikansky; Jeffrey E Green; Patricia K Donahoe; David T MacLaughlin; Shyamala Maheswaran
Mullerian inhibiting substance suppresses tumor growth in the C3(1)T antigen transgenic mouse mammary carcinoma model.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(9):3219-24.
2005: David E Kling; Jeremy T Aidlen; J C Fisher; T Bernard Kinane; Patricia K Donahoe; Jay J Schnitzer
Nitrofen induces a redox-dependent apoptosis associated with increased p38 activity in P19 teratocarcinoma cells.
Toxicology in vitro : an international journal published in association with BIBRA 2005;19(1):1-10.
2005: Elizabeth J Renaud; David T MacLaughlin; Esther Oliva; Bo R Rueda; Patricia K Donahoe
Endometrial cancer is a receptor-mediated target for Mullerian Inhibiting Substance.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(1):111-6.
2004: Nelson A Arango; Elliot J Pearson; Patricia K Donahoe; Jose Teixeira
Genomic structure and expression analysis of the mouse testis-specific ribbon protein (Trib) gene.
Gene 2004;343(1):221-7.
2004: Patricia K Donahoe
Sustained inquiry: in the clinic and at the bench.
Journal of pediatric surgery 2004;39(11):1601-6.
2004: Alexander M Trbovich; Nina Martinelle; Francis O'Neill; Elliot J Pearson; Patricia K Donahoe; patrick sluss; Jose Teixeira
Steroidogenic activities in MA-10 Leydig cells are differentially altered by cAMP and Müllerian inhibiting substance.
The Journal of steroid biochemistry and molecular biology 2004;92(3):199-208.
2004: Christopher P. Houk; Elliot J Pearson; Nina Martinelle; Patricia K Donahoe; Jose Teixeira
Feedback inhibition of steroidogenic acute regulatory protein expression in vitro and in vivo by androgens.
Endocrinology 2004;145(3):1269-75.
2004: Antonio Salva; Matthew P Hardy; Xiu-feng Wu; Chantal M Sottas; David T MacLaughlin; Patricia K Donahoe; Mary M Lee
Müllerian-inhibiting substance inhibits rat Leydig cell regeneration after ethylene dimethanesulphonate ablation.
Biology of reproduction 2004;70(3):600-7.
2004: David T MacLaughlin; Patricia K Donahoe
Sex determination and differentiation.
The New England journal of medicine 2004;350(4):367-78.
2003: Thanh U Barbie; David A Barbie; David T MacLaughlin; Shyamala Maheswaran; Patricia K Donahoe
Mullerian Inhibiting Substance inhibits cervical cancer cell growth via a pathway involving p130 and p107.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(26):15601-6.
2003: Yasunori Hoshiya; Vandana Gupta; Hirofumi Kawakubo; Elena F Brachtel; Jennifer L Carey; Laura M Sasur; Andrew Scott; Patricia K Donahoe; Shyamala Maheswaran
Mullerian inhibiting substance promotes interferon gamma-induced gene expression and apoptosis in breast cancer cells.
The Journal of biological chemistry 2003;278(51):51703-12.
2003: Patricia K Donahoe; Trent Clarke; Jose Teixeira; Shyamala Maheswaran; David T MacLaughlin
Enhanced purification and production of Müllerian inhibiting substance for therapeutic applications.
Molecular and cellular endocrinology 2003;211(1-2):37-42.
2003: Makiko Hoshiya; Benjamin P Christian; William J Cromie; Hyung Kim; Yong Zhan; David T MacLaughlin; Patricia K Donahoe
Persistent Mullerian duct syndrome caused by both a 27-bp deletion and a novel splice mutation in the MIS type II receptor gene.
Birth defects research. Part A, Clinical and molecular teratology 2003;67(10):868-74.
2003: Roshni Dasgupta; Jay J Schnitzer; W Hardy Hendren; Patricia K Donahoe
Congenital adrenal hyperplasia: surgical considerations required to repair a 46,XX patient raised as a boy.
Journal of pediatric surgery 2003;38(8):1269-73.
2003: Madhusmita Misra; David T MacLaughlin; Patricia K Donahoe; Mary M Lee
The role of Müllerian inhibiting substance in the evaluation of phenotypic female patients with mild degrees of virilization.
The Journal of clinical endocrinology and metabolism 2003;88(2):787-92.
2002: V Matt Laurich; Alexander M Trbovich; Francis O'Neill; Christopher P. Houk; patrick sluss; Anita H Payne; Patricia K Donahoe; Jose Teixeira
Müllerian inhibiting substance blocks the protein kinase A-induced expression of cytochrome p450 17alpha-hydroxylase/C(17-20) lyase mRNA in a mouse Leydig cell line independent of cAMP responsive element binding protein phosphorylation.
Endocrinology 2002;143(9):3351-60.
2002: Antonia E Stephen; Lisa A Pearsall; Benjamin P Christian; Patricia K Donahoe; Joseph P Vacanti; David T MacLaughlin
Highly purified müllerian inhibiting substance inhibits human ovarian cancer in vivo.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(8):2640-6.
2002: Madhusmita Misra; David T MacLaughlin; Patricia K Donahoe; Mary M Lee
Measurement of Mullerian inhibiting substance facilitates management of boys with microphallus and cryptorchidism.
The Journal of clinical endocrinology and metabolism 2002;87(8):3598-602.
2002: David E Kling; Hans Lorenzo; Alexander M Trbovich; T Bernard Kinane; Patricia K Donahoe; Jay J Schnitzer
MEK-1/2 inhibition reduces branching morphogenesis and causes mesenchymal cell apoptosis in fetal rat lungs.
American journal of physiology. Lung cellular and molecular physiology 2002;282(3):L370-8.
2002: Dorry L Segev; Yasunori Hoshiya; Makiko Hoshiya; Trinh T Tran; Jennifer L Carey; Antonia E Stephen; David T MacLaughlin; Patricia K Donahoe; Shyamala Maheswaran
Mullerian-inhibiting substance regulates NF-kappa B signaling in the prostate in vitro and in vivo.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(1):239-44.
2002: Hans Lorenzo; Jose Teixeira; Nima Pahlavan; V Matt Laurich; Patricia K Donahoe; David T MacLaughlin
New approaches for high-yield purification of Müllerian inhibiting substance improve its bioactivity.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2002;766(1):89-98.
2002: David T MacLaughlin; Patricia K Donahoe
Mullerian inhibiting substance: an update.
Advances in experimental medicine and biology 2002;511():25-38; discussion 38-40.
2001: Jose Teixeira; Shyamala Maheswaran; Patricia K Donahoe
Müllerian inhibiting substance: an instructive developmental hormone with diagnostic and possible therapeutic applications.
Endocrine reviews 2001;22(5):657-74.
2001: David E Kling; V Narra; S Islam; T Bernard Kinane; Alessandro Alessandrini; L Ercolani; Patricia K Donahoe; Jay J Schnitzer
Decreased mitogen activated protein kinase activities in congenital diaphragmatic hernia-associated pulmonary hypoplasia.
Journal of pediatric surgery 2001;36(10):1490-6.
2001: V Sriraman; Enmei Niu; J R Matias; Patricia K Donahoe; David T MacLaughlin; Matthew P Hardy; Mary M Lee
Müllerian inhibiting substance inhibits testosterone synthesis in adult rats.
Journal of andrology 2001;22(5):750-8.
2001: Dorry L Segev; Yasunori Hoshiya; Antonia E Stephen; Makiko Hoshiya; Trinh T Tran; David T MacLaughlin; Patricia K Donahoe; Shyamala Maheswaran
Mullerian inhibiting substance regulates NFkappaB signaling and growth of mammary epithelial cells in vivo.
The Journal of biological chemistry 2001;276(29):26799-806.
2001: TR Clarke; Yasunori Hoshiya; SE Yi; X Liu; Karen M Lyons; Patricia K Donahoe
Müllerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression.
Molecular endocrinology (Baltimore, Md.) 2001;15(6):946-59.
2001: Alexander M Trbovich; patrick sluss; V Matt Laurich; Francis O'Neill; David T MacLaughlin; Patricia K Donahoe; Jose Teixeira
Müllerian Inhibiting Substance lowers testosterone in luteinizing hormone-stimulated rodents.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(6):3393-7.
2001: Antonia E Stephen; Peter T Masiakos; Dorry L Segev; Joseph P Vacanti; Patricia K Donahoe; David T MacLaughlin
Tissue-engineered cells producing complex recombinant proteins inhibit ovarian cancer in vivo.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(6):3214-9.
2001: E Ukiyama; Agnes Jancso-Radek; Biaoru Li; L Milos; Wei Zhang; Nelson B Phillips; N Morikawa; C Y King; Ging Chan; CM Haqq; James T Radek; F Poulat; Patricia K Donahoe; Michael A Weiss
SRYand architectural gene regulation: the kinetic stability of a bent protein-DNA complex can regulate its transcriptional potency.
Molecular endocrinology (Baltimore, Md.) 2001;15(3):363-77.
2000: Thanh U Ha; Dorry L Segev; David A Barbie; Peter T Masiakos; Trinh T Tran; David Dombkowski; M Glander; TR Clarke; Hans Lorenzo; Patricia K Donahoe; Shyamala Maheswaran
Mullerian inhibiting substance inhibits ovarian cell growth through an Rb-independent mechanism.
The Journal of biological chemistry 2000;275(47):37101-9.
2000: N Morikawa; TR Clarke; Carl D Novina; K Watanabe; CM Haqq; M Weiss; Ananda L Roy; Patricia K Donahoe
Human Müllerian-inhibiting substance promoter contains a functional TFII-I-binding initiator.
Biology of reproduction 2000;63(4):1075-83.
2000: Dorry L Segev; Thanh U Ha; Trinh T Tran; M Kenneally; P Harkin; M Jung; David T MacLaughlin; Patricia K Donahoe; Shyamala Maheswaran
Mullerian inhibiting substance inhibits breast cancer cell growth through an NFkappa B-mediated pathway.
The Journal of biological chemistry 2000;275(37):28371-9.
2000: S Paul Oh; Tsugio Seki; K A Goss; T Imamura; Yong Yi; Patricia K Donahoe; Li Li; K Miyazono; Peter ten Dijke; S Kim; En Li
Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(6):2626-31.
2000: K Watanabe; TR Clarke; Andrew lane; Xiaomei Wang; Patricia K Donahoe
Endogenous expression of Müllerian inhibiting substance in early postnatal rat sertoli cells requires multiple steroidogenic factor-1 and GATA-4-binding sites.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(4):1624-9.
1999: Jose Teixeira; DJ Kehas; R Antun; Patricia K Donahoe
Transcriptional regulation of the rat Müllerian inhibiting substance type II receptor in rodent Leydig cells.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(24):13831-8.
1999: Peter T Masiakos; David T MacLaughlin; Shyamala Maheswaran; Jose Teixeira; Arlan F Fuller; P C Shah; DJ Kehas; M K Kenneally; David Dombkowski; Thanh U Ha; Frederic Preffer; Patricia K Donahoe
Human ovarian cancer, cell lines, and primary ascites cells express the human Mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MIS.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(11):3488-99.
1999: Jose Teixeira; E Fynn-Thompson; A H Payne; Patricia K Donahoe
Müllerian-inhibiting substance regulates androgen synthesis at the transcriptional level.
Endocrinology 1999;140(10):4732-8.
1999: Mary M Lee; Ching Ching Seah; Peter T Masiakos; Chantal M Sottas; Frederic Preffer; Patricia K Donahoe; David T MacLaughlin; Matthew P Hardy
Müllerian-inhibiting substance type II receptor expression and function in purified rat Leydig cells.
Endocrinology 1999;140(6):2819-27.
1999: S Islam; Patricia K Donahoe; Jay J Schnitzer
Tracheal ligation increases mitogen-activated protein kinase activity and attenuates surfactant protein B mRNA in fetal sheep lungs.
The Journal of surgical research 1999;84(1):19-23.
1999: Z Gu; E M Reynolds; Jihwan Song; Hong Lei; A Feijen; L Yu; W He; David T MacLaughlin; J van den Eijnden-van Raaij; Patricia K Donahoe; En Li
The type I serine/threonine kinase receptor ActRIA (ALK2) is required for gastrulation of the mouse embryo.
Development (Cambridge, England) 1999;126(11):2551-61.
1999: Andrew lane; Mary M Lee; Arlan F Fuller; DJ Kehas; Patricia K Donahoe; David T MacLaughlin
Diagnostic utility of Müllerian inhibiting substance determination in patients with primary and recurrent granulosa cell tumors.
Gynecologic oncology 1999;73(1):51-5.
1999: Yutaka Morita; Thomas F Manganaro; XJ Tao; S Martimbeau; Patricia K Donahoe; Jonathan L Tilly
Requirement for phosphatidylinositol-3'-kinase in cytokine-mediated germ cell survival during fetal oogenesis in the mouse.
Endocrinology 1999;140(2):941-9.
1999: S Islam; V Narra; G M Coté; Thomas F Manganaro; Patricia K Donahoe; Jay J Schnitzer
Prenatal vitamin E treatment improves lung growth in fetal rats with congenital diaphragmatic hernia.
Journal of pediatric surgery 1999;34(1):172-6 discussion 176-7.
1998: Andrew lane; Patricia K Donahoe
New insights into mullerian inhibiting substance and its mechanism of action.
The Journal of endocrinology 1998;158(1):1-6.
1998: Z Gu; Masatoshi Nomura; B B Simpson; Hong Lei; A Feijen; J van den Eijnden-van Raaij; Patricia K Donahoe; En Li
The type I activin receptor ActRIB is required for egg cylinder organization and gastrulation in the mouse.
Genes & development 1998;12(6):844-57.
1998: CM Haqq; Patricia K Donahoe
Regulation of sexual dimorphism in mammals.
Physiological reviews 1998;78(1):1-33.
1997: Peter T Masiakos; C E Flynn; Patricia K Donahoe
Masculinizing and feminizing syndromes caused by functioning tumors.
Seminars in pediatric surgery 1997;6(3):147-55.
1997: H Ijsselstijn; BA Pacheco; A Albert; Wim Sluiter; Patricia K Donahoe; Johan C de Jongste; Jay J Schnitzer; Dick Tibboel
Prenatal hormones alter antioxidant enzymes and lung histology in rats with congenital diaphragmatic hernia.
The American journal of physiology 1997;272(6 Pt 1):L1059-65.
1997: Mary M Lee; Patricia K Donahoe; B L Silverman; T Hasegawa; Y Hasegawa; M L Gustafson; Y C Chang; David T MacLaughlin
Measurements of serum müllerian inhibiting substance in the evaluation of children with nonpalpable gonads.
The New England journal of medicine 1997;336(21):1480-6.
1997: HL Hedrick; Jody Kaban; BA Pacheco; Paul D Losty; Daniel P Doody; Daniel P Ryan; Thomas F Manganaro; Patricia K Donahoe; Jay J Schnitzer
Prenatal glucocorticoids improve pulmonary morphometrics in fetal sheep with congenital diaphragmatic hernia.
Journal of pediatric surgery 1997;32(2):217-21; discussion 221-2.
1997: E A Catlin; V C Tonnu; R G Ebb; BA Pacheco; Thomas F Manganaro; Robert Ezzell; Patricia K Donahoe; Jose Teixeira
Müllerian inhibiting substance inhibits branching morphogenesis and induces apoptosis in fetal rat lung.
Endocrinology 1997;138(2):790-6.
1997: M M Lee; Patricia K Donahoe
The infant with ambiguous genitalia.
Current therapy in endocrinology and metabolism 1997;6():216-23.
1996: Dietrich Kluth; Paul D Losty; Jay J Schnitzer; Wolfgang Lambrecht; Patricia K Donahoe
Toward understanding the developmental anatomy of congenital diaphragmatic hernia.
Clinics in perinatology 1996;23(4):655-69.
1996: Jay J Schnitzer; H L Hedrick; B A Pacheco; Paul D Losty; Daniel P Ryan; Daniel P Doody; Patricia K Donahoe
Prenatal glucocorticoid therapy reverses pulmonary immaturity in congenital diaphragmatic hernia in fetal sheep.
Annals of surgery 1996;224(4):430-7; discussion 437-9.
1996: Paul D Losty; B A Pacheco; Thomas F Manganaro; Patricia K Donahoe; R C Jones; Jay J Schnitzer
Prenatal hormonal therapy improves pulmonary morphology in rats with congenital diaphragmatic hernia.
The Journal of surgical research 1996;65(1):42-52.
1996: Tongwen Wang; B Y Li; P D Danielson; P C Shah; S Rockwell; R J Lechleider; J Martin; T Manganaro; Patricia K Donahoe
The immunophilin FKBP12 functions as a common inhibitor of the TGF beta family type I receptors.
Cell 1996;86(3):435-44.
1996: B B Simpson; Daniel P Ryan; Patricia K Donahoe; Jay J Schnitzer; S H Kim; Daniel P Doody
Type IV laryngotracheoesophageal clefts: surgical management for long-term survival.
Journal of pediatric surgery 1996;31(8):1128-33.
1996: P C Shah; B B Simpson; Patricia K Donahoe
Müllerian inhibiting substance as a model for the transforming growth factor-beta family: development of new treatment strategies.
Seminars in pediatric surgery 1996;5(3):182-90.
1996: J Teixeira; Patricia K Donahoe
Molecular biology of MIS and its receptors.
Journal of andrology 1996;17(4):336-41.
1996: Tongwen Wang; P D Danielson; B Y Li; P C Shah; S D Kim; Patricia K Donahoe
The p21(RAS) farnesyltransferase alpha subunit in TGF-beta and activin signaling.
Science (New York, N.Y.) 1996;271(5252):1120-2.
1996: Mary M Lee; Patricia K Donahoe; T Hasegawa; B Silverman; G B Crist; S Best; Y Hasegawa; R A Noto; D Schoenfeld; David T MacLaughlin
Mullerian inhibiting substance in humans: normal levels from infancy to adulthood.
The Journal of clinical endocrinology and metabolism 1996;81(2):571-6.
1996: M A Maggard; E A Catlin; P L Hudson; Patricia K Donahoe; David T MacLaughlin
Reduction of epidermal growth factor receptor phosphorylation by activated Mullerian inhibiting substance is vanadate-sensitive.
Metabolism: clinical and experimental 1996;45(2):190-5.
1996: Jose Teixeira; W W He; P C Shah; N Morikawa; Mary M Lee; E A Catlin; P L Hudson; J Wing; David T MacLaughlin; Patricia K Donahoe
Developmental expression of a candidate müllerian inhibiting substance type II receptor.
Endocrinology 1996;137(1):160-5.
1995: R Peters; C Y King; E Ukiyama; S Falsafi; Patricia K Donahoe; Michael A Weiss
An SRY mutation causing human sex reversal resolves a general mechanism of structure-specific DNA recognition: application to the four-way DNA junction.
Biochemistry 1995;34(14):4569-76.
1995: M S Kurian; R S de la Cuesta; G L Waneck; David T MacLaughlin; Thomas F Manganaro; Patricia K Donahoe
Cleavage of Müllerian inhibiting substance activates antiproliferative effects in vivo.
Clinical cancer research : an official journal of the American Association for Cancer Research 1995;1(3):343-9.
1995: Paul D Losty; Hon Chi Suen; Thomas F Manganaro; Patricia K Donahoe; Jay J Schnitzer
Prenatal hormonal therapy improves pulmonary compliance in the nitrofen-induced CDH rat model.
Journal of pediatric surgery 1995;30(3):420-6.
1995: A J Alles; Paul D Losty; Patricia K Donahoe; Thomas F Manganaro; Jay J Schnitzer
Embryonic cell death patterns associated with nitrofen-induced congenital diaphragmatic hernia.
Journal of pediatric surgery 1995;30(2):353-8; discussion 359-60.
1994: C M Haqq; C Y King; E Ukiyama; S Falsafi; T N Haqq; Patricia K Donahoe; Michael A Weiss
Molecular basis of mammalian sexual determination: activation of Müllerian inhibiting substance gene expression by SRY.
Science (New York, N.Y.) 1994;266(5190):1494-500.
1994: Vicki N Meyers-Wallen; David T MacLaughlin; V Palmer; Patricia K Donahoe
Mullerian-inhibiting substance secretion is delayed in XX sex-reversed dog embryos.
Molecular reproduction and development 1994;39(1):1-7.
1994: P L Hudson; Ward Anthony Pedersen; W S Saltsman; Mordechai Liscovitch; David T MacLaughlin; Patricia K Donahoe; Jan Krzysztof Blusztajn
Modulation by sphingolipids of calcium signals evoked by epidermal growth factor.
The Journal of biological chemistry 1994;269(34):21885-90.
1994: Hon Chi Suen; Paul D Losty; Patricia K Donahoe; Jay J Schnitzer
Accurate method to study static volume-pressure relationships in small fetal and neonatal animals.
Journal of applied physiology (Bethesda, Md. : 1985) 1994;77(2):1036-43.
1994: S Hirobe; W W He; M L Gustafson; David T MacLaughlin; Patricia K Donahoe
Müllerian inhibiting substance gene expression in the cycling rat ovary correlates with recruited or graafian follicle selection.
Biology of reproduction 1994;50(6):1238-43.
1994: C H Bassing; D J Howe; P R Segarini; Patricia K Donahoe; Xiao-Fan Wang
A single heteromeric receptor complex is sufficient to mediate biological effects of transforming growth factor-beta ligands.
The Journal of biological chemistry 1994;269(21):14861-4.
1994: Hon Chi Suen; Kenneth D Bloch; Patricia K Donahoe
Antenatal glucocorticoid corrects pulmonary immaturity in experimentally induced congenital diaphragmatic hernia in rats.
Pediatric research 1994;35(5):523-9.
1994: Mary M Lee; M L Gustafson; E Ukiyama; Patricia K Donahoe; David T MacLaughlin; M Wexler; Hugh Keeping
Developmental changes in mullerian inhibiting substance in the cynomolgus monkey, Macaca fascicularis.
The Journal of clinical endocrinology and metabolism 1994;78(3):615-21.
1994: Hon Chi Suen; Paul D Losty; Patricia K Donahoe; Jay J Schnitzer
Combined antenatal thyrotropin-releasing hormone and low-dose glucocorticoid therapy improves the pulmonary biochemical immaturity in congenital diaphragmatic hernia.
Journal of pediatric surgery 1994;29(2):359-63.
1994: C H Bassing; J M Yingling; D J Howe; Tongwen Wang; W W He; M L Gustafson; P Shah; Patricia K Donahoe; Xiao-Fan Wang
A transforming growth factor beta type I receptor that signals to activate gene expression.
Science (New York, N.Y.) 1994;263(5143):87-9.
1994: M L Gustafson; Patricia K Donahoe
Male sex determination: current concepts of male sexual differentiation.
Annual review of medicine 1994;45():505-24.
1994: Mary M Lee; Patricia K Donahoe
Ambiguous genitalia.
Current therapy in endocrinology and metabolism 1994;5():242-9.
1993: E A Catlin; Robert Ezzell; Patricia K Donahoe; M L Gustafson; E V Son; David T MacLaughlin
Identification of a receptor for human müllerian inhibiting substance.
Endocrinology 1993;133(6):3007-13.
1993: E A Catlin; David T MacLaughlin; Patricia K Donahoe
Müllerian inhibiting substance: new perspectives and future directions.
Microscopy research and technique 1993;25(2):121-33.
1993: Vicki N Meyers-Wallen; Mary M Lee; Thomas F Manganaro; T Kuroda; David T MacLaughlin; Patricia K Donahoe
Müllerian inhibiting substance is present in embryonic testes of dogs with persistent müllerian duct syndrome.
Biology of reproduction 1993;48(6):1410-8.
1993: Mary M Lee; Patricia K Donahoe
Mullerian inhibiting substance: a gonadal hormone with multiple functions.
Endocrine reviews 1993;14(2):152-64.
1993: Hon Chi Suen; E A Catlin; Daniel P Ryan; John C Wain; Patricia K Donahoe
Biochemical immaturity of lungs in congenital diaphragmatic hernia.
Journal of pediatric surgery 1993;28(3):471-5; discussion 476-7.
1993: M L Gustafson; Mary M Lee; L Asmundson; David T MacLaughlin; Patricia K Donahoe
Müllerian inhibiting substance in the diagnosis and management of intersex and gonadal abnormalities.
Journal of pediatric surgery 1993;28(3):439-44.
1993: C M Haqq; C Y King; Patricia K Donahoe; Michael A Weiss
SRY recognizes conserved DNA sites in sex-specific promoters.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(3):1097-101.
1993: W W He; M L Gustafson; S Hirobe; Patricia K Donahoe
Developmental expression of four novel serine/threonine kinase receptors homologous to the activin/transforming growth factor-beta type II receptor family.
Developmental dynamics : an official publication of the American Association of Anatomists 1993;196(2):133-42.
1992: David T MacLaughlin; Robin Levin; E A Catlin; Lesli Taylor; Frederic Preffer; Patricia K Donahoe
Identification of müllerian inhibiting substance specific binding in human cell lines.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 1992;24(12):570-5.
1992: S Hirobe; W W He; Mary M Lee; Patricia K Donahoe
Mullerian inhibiting substance messenger ribonucleic acid expression in granulosa and Sertoli cells coincides with their mitotic activity.
Endocrinology 1992;131(2):854-62.
1992: David T MacLaughlin; P L Hudson; A L Graciano; M K Kenneally; R C Ragin; Thomas F Manganaro; Patricia K Donahoe
Mullerian duct regression and antiproliferative bioactivities of mullerian inhibiting substance reside in its carboxy-terminal domain.
Endocrinology 1992;131(1):291-6.
1992: R C Ragin; Patricia K Donahoe; M K Kenneally; M F Ahmad; David T MacLaughlin
Human müllerian inhibiting substance: enhanced purification imparts biochemical stability and restores antiproliferative effects.
Protein expression and purification 1992;3(3):236-45.
1992: C Haqq; M M Lee; R Tizard; M Wysk; J DeMarinis; Patricia K Donahoe; Richard L Cate
Isolation of the rat gene for Mullerian inhibiting substance.
Genomics 1992;12(4):665-9.
1992: E A Catlin; Robert Ezzell; Patricia K Donahoe; Thomas F Manganaro; R G Ebb; David T MacLaughlin
Mullerian inhibiting substance binding and uptake.
Developmental dynamics : an official publication of the American Association of Anatomists 1992;193(4):295-9.
1992: R L Parry; T W Chin; J Epstein; P L Hudson; D M Powell; Patricia K Donahoe
Recombinant human mullerian inhibiting substance inhibits human ocular melanoma cell lines in vitro and in vivo.
Cancer research 1992;52(5):1182-6.
1992: S Hirobe; Daniel P Doody; Daniel P Ryan; S H Kim; Patricia K Donahoe
Ectopic class II major histocompatibility antigens in Hirschsprung's disease and neuronal intestinal dysplasia.
Journal of pediatric surgery 1992;27(3):357-62; discussion 363.
1992: M L Gustafson; Mary M Lee; R E Scully; A C Moncure; T Hirakawa; A Goodman; H G Muntz; Patricia K Donahoe; David T MacLaughlin; Arlan F Fuller
Müllerian inhibiting substance as a marker for ovarian sex-cord tumor.
The New England journal of medicine 1992;326(7):466-71.
1991: T Kuroda; M M Lee; R C Ragin; S Hirobe; Patricia K Donahoe
Müllerian inhibiting substance production and cleavage is modulated by gonadotropins and steroids.
Endocrinology 1991;129(6):2985-92.
1991: E A Catlin; N D Uitvlugt; Patricia K Donahoe; D M Powell; M Hayashi; David T MacLaughlin
Müllerian inhibiting substance blocks epidermal growth factor receptor phosphorylation in fetal rat lung membranes.
Metabolism: clinical and experimental 1991;40(11):1178-84.
1991: Vicki N Meyers-Wallen; Thomas F Manganaro; T Kuroda; PW Concannon; David T MacLaughlin; Patricia K Donahoe
The critical period for mullerian duct regression in the dog embryo.
Biology of reproduction 1991;45(4):626-33.
1991: Daniel P Ryan; D D Muehrcke; Daniel P Doody; S H Kim; Patricia K Donahoe
Laryngotracheoesophageal cleft (type IV): management and repair of lesions beyond the carina.
Journal of pediatric surgery 1991;26(8):962-9; discussion 969-70.
1991: E M Barksdale; T G McGenis; Patricia K Donahoe
Gonadotropins moderate rejection of trophic-specific congenic testes grafts.
Journal of pediatric surgery 1991;26(8):886-92.
1991: Patricia K Donahoe; D M Powell; Mary M Lee
Clinical management of intersex abnormalities.
Current problems in surgery 1991;28(8):513-79.
1991: T Kuroda; Daniel P Doody; Patricia K Donahoe
Aberrant colonic expression of MHC class II antigens in Hirschsprung's disease.
The Australian and New Zealand journal of surgery 1991;61(5):373-9.
1991: T W Chin; R L Parry; Patricia K Donahoe
Human müllerian inhibiting substance inhibits tumor growth in vitro and in vivo.
Cancer research 1991;51(8):2101-6.
1990: T Kuroda; Mary M Lee; C M Haqq; D M Powell; Thomas F Manganaro; Patricia K Donahoe
Mullerian inhibiting substance ontogeny and its modulation by follicle-stimulating hormone in the rat testes.
Endocrinology 1990;127(4):1825-32.
1990: E A Catlin; S M Powell; Thomas F Manganaro; P L Hudson; R C Ragin; J Epstein; Patricia K Donahoe
Sex-specific fetal lung development and müllerian inhibiting substance.
The American review of respiratory disease 1990;141(2):466-70.
1990: P L Hudson; I Dougas; Patricia K Donahoe; Richard L Cate; J Epstein; R Blake Pepinsky; David T MacLaughlin
An immunoassay to detect human müllerian inhibiting substance in males and females during normal development.
The Journal of clinical endocrinology and metabolism 1990;70(1):16-22.
1989: Vicki N Meyers-Wallen; Patricia K Donahoe; S Ueno; Thomas F Manganaro; Donald F Patterson
Müllerian inhibiting substance is present in testes of dogs with persistent müllerian duct syndrome.
Biology of reproduction 1989;41(5):881-8.
1989: S Ueno; T Kuroda; David T MacLaughlin; R C Ragin; Thomas F Manganaro; Patricia K Donahoe
Mullerian inhibiting substance in the adult rat ovary during various stages of the estrous cycle.
Endocrinology 1989;125(2):1060-6.
1989: J Epstein; E J Desjardins; P L Hudson; Patricia K Donahoe
Stainless steel mesh supports high density cell growth and production of recombinant müllerian inhibiting substances.
In vitro cellular & developmental biology : journal of the Tissue Culture Association 1989;25(2):213-6.
1989: S Ueno; M Takahashi; Thomas F Manganaro; R C Ragin; Patricia K Donahoe
Cellular localization of müllerian inhibiting substance in the developing rat ovary.
Endocrinology 1989;124(2):1000-6.
1989: F G Cigarroa; J P Coughlin; Patricia K Donahoe; M F White; N Uitvlugt; David T MacLaughlin
Recombinant human müllerian inhibiting substance inhibits epidermal growth factor receptor tyrosine kinase.
Growth factors (Chur, Switzerland) 1989;1(2):179-91.
1988: E A Catlin; Thomas F Manganaro; Patricia K Donahoe
Müllerian inhibiting substance depresses accumulation in vitro of disaturated phosphatidylcholine in fetal rat lung.
American journal of obstetrics and gynecology 1988;159(5):1299-303.
1988: S Ueno; Thomas F Manganaro; Patricia K Donahoe
Human recombinant mullerian inhibiting substance inhibition of rat oocyte meiosis is reversed by epidermal growth factor in vitro.
Endocrinology 1988;123(3):1652-9.
1988: J P Coughlin; F Cigarroa; Patricia K Donahoe; D T McLaughlin
Human recombinant mullerian inhibiting substance inhibits epidermal growth factor.
Current surgery 1988;45(3):204-5.
1988: Patricia K Donahoe
Neoseminal vesicle created from retained mullerian duct to preserve the vas in male infants.
Journal of pediatric surgery 1988;23(3):272-4.
1988: F G Cigarroa; S H Kim; Patricia K Donahoe
Imperforate anus with long but apparent low fistula in females.
Journal of pediatric surgery 1988;23(1 Pt 2):42-4.
1988: Patricia K Donahoe; M Takahashi; S Ueno; Thomas F Manganaro
Mullerian inhibiting substance in the ovary.
Progress in clinical and biological research 1988;267():153-75.
1987: Vicki N Meyers-Wallen; Patricia K Donahoe; Thomas F Manganaro; Donald F Patterson
Müllerian inhibiting substance in sex-reversed dogs.
Biology of reproduction 1987;37(4):1015-22.
1987: Patricia K Donahoe
The diagnosis and treatment of infants with intersex abnormalities.
Pediatric clinics of North America 1987;34(5):1333-48.
1987: Patricia K Donahoe; Richard L Cate; David T MacLaughlin; J Epstein; Arlan F Fuller; M Takahashi; J P Coughlin; E G Ninfa; Lesli Taylor
Müllerian inhibiting substance: gene structure and mechanism of action of a fetal regressor.
Recent progress in hormone research 1987;43():431-67.
1987: J P Coughlin; Patricia K Donahoe; G P Budzik; David T MacLaughlin
Müllerian inhibiting substance blocks autophosphorylation of the EGF receptor by inhibiting tyrosine kinase.
Molecular and cellular endocrinology 1987;49(1):75-86.
1986: E C Necklaws; M P LaQuaglia; David T MacLaughlin; P Hudson; M Mudgett-Hunter; Patricia K Donahoe
Detection of Müllerian inhibiting substance in biological samples by a solid phase sandwich radioimmunoassay.
Endocrinology 1986;118(2):791-6.
1986: Richard L Cate; E G Ninfa; D J Pratt; David T MacLaughlin; Patricia K Donahoe
Development of mullerian inhibiting substance as an anti-cancer drug.
Cold Spring Harbor symposia on quantitative biology 1986;51 Pt 1():641-7.
1985: A F Fuller; I M Krane; G P Budzik; Patricia K Donahoe
Mullerian inhibiting substance reduction of colony growth of human gynecologic cancers in a stem cell assay.
Gynecologic oncology 1985;22(2):135-48.
1984: Patricia K Donahoe; I Krane; A E Bogdén; S Kamagata; G P Budzik
Subrenal capsule assay to test the viability of parenterally delivered müllerian inhibiting substance.
Journal of pediatric surgery 1984;19(6):863-9.
1984: H Ikawa; J M Hutson; G P Budzik; Patricia K Donahoe
Cyclic adenosine 3',5'-monophosphate modulation of mullerian duct regression.
Endocrinology 1984;114(5):1686-91.
1984: M E Fallat; J M Hutson; G P Budzik; Patricia K Donahoe
Androgen stimulation of nucleotide pyrophosphatase during mullerian duct regression.
Endocrinology 1984;114(5):1592-8.
1984: H Ikawa; R L Trelstad; J M Hutson; T F Manganaro; Patricia K Donahoe
Changing patterns of fibronectin, laminin, type IV collagen, and a basement membrane proteoglycan during rat Mullerian duct regression.
Developmental biology 1984;102(1):260-3.
1984: J M Hutson; M E Fallat; S Kamagata; Patricia K Donahoe; G P Budzik
Phosphorylation events during Müllerian duct regression.
Science (New York, N.Y.) 1984;223(4636):586-9.
1984: H Shima; Patricia K Donahoe; G P Budzik; S Kamagata; P Hudson; M Mudgett-Hunter
Production of monoclonal antibodies for affinity purification of bovine mullerian inhibiting substance activity.
Hybridoma 1984;3(3):201-14.
1984: A F Fuller; G P Budzik; I M Krane; Patricia K Donahoe
Müllerian inhibiting substance inhibition of a human endometrial carcinoma cell line xenografted in nude mice.
Gynecologic oncology 1984;17(1):124-32.
1984: B R Schwartz; R L Trelstad; J M Hutson; H Ikawa; Patricia K Donahoe
Zinc chelation and mullerian duct regression.
Journal of experimental pathology 1984;1(2):143-56.
1984: Patricia K Donahoe; J M Hutson; M E Fallat; S Kamagata; G P Budzik
Mechanism of action of Mullerian inhibiting substance.
Annual review of physiology 1984;46():53-65.
1983: M E Fallat; J M Hutson; G P Budzik; Patricia K Donahoe
The role of nucleotide pyrophosphatase in Mullerian duct regression.
Developmental biology 1983;100(2):358-64.
1983: G P Budzik; S M Powell; S Kamagata; Patricia K Donahoe
Mullerian inhibiting substance fractionation by dye affinity chromatography.
Cell 1983;34(1):307-14.
1983: J M Hutson; David T MacLaughlin; H Ikawa; G P Budzik; Patricia K Donahoe
Regression of the Müllerian ducts during sexual differentiation in the chick embryo. A reappraisal.
International review of physiology 1983;27():177-224.
1983: M Mudgett-Hunter; G P Budzik; Patricia K Donahoe; B A Khaw; Michael N Margolies; E C Ridgeway; E Haber
Monoclonal antibodies as physiologic probes.
Basic life sciences 1983;25():101-28.
1982: H Ikawa; J M Hutson; G P Budzik; David T MacLaughlin; Patricia K Donahoe
Steroid enhancement of Mullerian duct regression.
Journal of pediatric surgery 1982;17(5):453-8.
1982: A Hayashi; Patricia K Donahoe; G P Budzik; R L Trelstad
Periductal and matrix glycosaminoglycans in rat Mullerian duct development and regression.
Developmental biology 1982;92(1):16-26.
1982: A F Fuller; S Guy; G P Budzik; Patricia K Donahoe
Mullerian inhibiting substance inhibits colony growth of a human ovarian carcinoma cell line.
The Journal of clinical endocrinology and metabolism 1982;54(5):1051-5.
1982: G P Budzik; J M Hutson; H Ikawa; Patricia K Donahoe
The role of zinc in Müllerian duct regression.
Endocrinology 1982;110(5):1521-5.
1982: M Mudgett-Hunter; G P Budzik; M Sullivan; Patricia K Donahoe
Monoclonal antibody to Mullerian inhibiting substance.
Journal of immunology (Baltimore, Md. : 1950) 1982;128(3):1327-33.
1982: Patricia K Donahoe; G P Budzik; R Trelstad; M Mudgett-Hunter; A Fuller; J M Hutson; H Ikawa; A Hayashi; David T MacLaughlin
Müllerian-inhibiting substance: an update.
Recent progress in hormone research 1982;38():279-330.
1981: Patricia K Donahoe; A F Fuller; R E Scully; S R Guy; G P Budzik
Mullerian inhibiting substance inhibits growth of a human ovarian cancer in nude mice.
Annals of surgery 1981;194(4):472-80.